Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3107 results found
Expand All
Apply All
3107 results found

BIO Submits Testimony to House Science Subcommittee Hearing on Sustainable Aviation Fuels
Share
Agriculture & Environment, Sustainable Fuels, Climate Change  •  Letters, Testimony & Comments  •  March 24, 2021
The Biotechnology Innovation Organization is pleased to submit a statement for the record to the United States House of Representatives Committee on Science and Technology and Space and Aeronautics Subcommittee hearing entitled, "Examining R&D Pathways to Sustainable Aviation." BIO applauds the committee for holding this hearing on sustainable aviation. To tackle the climate crisis, it is crucial to lead with science and U.S. innovation. We must incentivize the adoption of innovative and sustainable technologies and practices and streamline and expedite regulatory pathways for new technology solutions to reduce carbon in hard to abate sectors. In doing so, the federal government can support pioneering breakthroughs that reduce greenhouse gas emissions in manufacturing, transportation, and agricultural supply chains to build a stronger, more resilient, and environmentally sustainable economy. BIO is committed to working with the Committee, Congress, and the Administration to address the climate crisis. Policy that advances pioneering technology like SAF will lead to breakthroughs reducing emissions in the aviation sector. By supporting science and innovation, we can return our Nation and the world to health and prosperity by taking bold and drastic action to address the climate crisis.
Read More

Why price controls won’t work
Share
Good Day BIO Newsletter  •  March 24, 2021
We tell you what you need to know about yesterday’s drug pricing legislation and hearing—and why this approach won’t work. We also preview today’s House hearing on SAF and introduce you to the Chinese pharmaceutical chemist who won a Nobel for discovering a treatment for malaria. (1,028 words, 5 minutes, 8 seconds)
Read More

Feeding Americans and the economy
Share
Good Day BIO Newsletter  •  March 23, 2021
It’s National Agriculture Day—so we have a sneak peek at a new report on the economic impact of the food and ag sector. We also report breaking news on a COVID-19 therapeutic as well as what to know about today’s jam-packed schedule in Congress. (1,016 words, 5 minutes)
Read More

BIO Letter to New Mexico Governor on Clean Fuel Standard in Special Session
Share
Agriculture & Environment, Sustainable Fuels  •  Letters, Testimony & Comments  •  March 22, 2021
I write today on behalf of the Biotechnology Industry Organization (BIO) – the world’s largest biotechnology trade group – to urge you to put Senate Bill 11 – the New Mexico Clean Fuel Standard Act – on the agenda for the March 31 special session of the New Mexico Legislature. I appreciate your leadership in pushing SB 11 during the 2021 regular session of the Legislature and respectfully ask that you add it to the agenda for the special session.
Read More

What's on the ag agenda?
Share
Good Day BIO Newsletter  •  March 22, 2021
Starting a new week with a look at the Biden administration’s agriculture policy agenda and the future of mRNA medicine, as well as the woman responsible for the modern face mask. (939 words, 4 minutes, 41 seconds)
Read More

Clinical Development Success Rates and Contributing Factors 2011-2020
Share

What to expect from the Biden administration’s trade agenda
Share
Good Day BIO Newsletter  •  March 19, 2021
Ending the week with Katherine Tai’s historic confirmation as U.S. Trade Representative and what we can expect from the administration’s trade agenda, as well as what policymakers and federal health officials said this week about COVID-19 vaccines. We also meet the Japanese American researcher whose work led to the discovery of the polio vaccine. (975 words, 4 minutes, 52 seconds)
Read More

BIO Welcomes Collaboration With New HHS, USTR Leaders
Share
Human Health, Cost & Value of Biopharmaceuticals  •  Press Release  •  March 18, 2021
The Biotechnology Innovation Organization (BIO) welcomes the confirmations this week of Katherine Tai to the position of U.S. Trade Representative (USTR) and Xavier Becerra to lead the Department of Health and Human Services (HHS).  The United States leads the world in biotechnology innovation, creating hundreds of thousands of good jobs. Our members are critical to addressing global health, agricultural, nutrition, and climate sustainability challenges. This includes the very important task of bringing an end to the current COVID-19 pandemic. On the confirmation of HHS Secretary Xavier Becerra, Dr. Michelle McMurry-Heath, president and CEO of BIO, released the following statement: “We congratulate Mr. Becerra on his confirmation to lead the Department of Health and Human Services. “HHS has already played, and will continue to play, a critical role in ending this global pandemic, addressing health disparities, and finding solutions to other issues facing our health system. “BIO looks forward to working with Mr. Becerra and his colleagues in HHS to defeat COVID-19, prepare for future pandemics, and promote patient-centered solutions that prioritize access and lasting biomedical innovation.” On the confirmation of Katherine Tai to USTR, Dr. McMurry-Heath said: “Trade policy has a critical role to play in helping the biotech sector fulfill its potential for the American worker and for humanity. “The hundreds of small companies that comprise our sector especially need help in global markets to ensure a level playing field and to protect against the unfair appropriation of world-leading U.S. technology. “Moreover, the importance of maintaining resilient and diverse supply chains, and refraining from export restrictions for COVID products is crucial as our sector works with global partners through COVAX and other initiatives to ensure that patients around the world get access to COVID vaccines and treatments. “We look forward to working with Ambassador…
Read More

BIO Testimony to House Energy and Commerce Subcommittee Hearing on the CLEAN Future Act
Share
Agriculture & Environment, Food & Farm Innovation, Sustainable Fuels  •  Letters, Testimony & Comments  •  March 18, 2021
The Biotechnology Innovation Organization (BIO) is pleased to submit a statement for the record to the United States House of Representatives Committee on Energy and Commerce Subcommittee on Environment and Climate Change hearing entitled, "The CLEAN Future Act: Industrial Climate Policies to Create Jobs and Support Working Communities." To tackle the climate crisis, it is crucial to lead with science and U.S. innovation. We must incentivize the adoption of innovative and sustainable technologies and practices and streamline and expedite regulatory pathways for breakthrough technology solutions to reduce carbon in hard-to-abate sectors.  BIO is committed to working with Committee, Congress, and the Administration to address the climate crisis. We urge to support policy that advances pioneering technology breakthroughs. With science, we can return our Nation and the world to health and prosperity by taking bold and drastic action to address the climate crisis.       
Read More

Action to improve U.S. R&D policy
Share
Good Day BIO Newsletter  •  March 18, 2021
A busy Thursday with a look at U.S. R&D policy, U.K. gene editing policy, and confirmations and hearings to watch in Congress. (1,000 words, 5 minutes)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 186
  • 187
  • 188
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO